跳至主要内容
临床试验/NCT00076973
NCT00076973已完成3 期

A Randomized, 2-Period, Multicenter, Dble-Blind, Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w/ Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths

Organon and Co0 个研究点目标入组 1,125 人开始时间: 2003年8月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
1,125
主要终点
Percentage of Symptom-Free Days

研究概览

简要总结

The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
3 Months 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Hospitalized or in an urgent/emergent-care setting at least 24 hours for a first or second episode of RSV-induced bronchiolitis. Approximately twenty percent of patients will be allowed in the study with a stay of less than 24 hours but need to meet a minimum predefined Respiratory Severity Score as required by the study.

排除标准

  • Asthma or other wheezing disorder. The Primary Investigator will evaluate whether there are other reasons why a child may not participate.

结局指标

主要结局

Percentage of Symptom-Free Days

次要结局

  • Percentage of Patients with Exacerbations and Percentage of Bronchiolitis-Free Days

研究者

申办方类型
Industry
责任方
Sponsor

相似试验